On May 1, 2026, the Fifth Circuit Court of Appeals ruled to temporarily reinstate in-person dispensing requirements for the abortion pill mifepristone — blocking its delivery by mail or telemedicine nationwide.
The ruling paused 2023 FDA regulations to allow remote prescribing and was immediately appealed to the Supreme Court.
Dr. Christina Francis tells BlazeTV host Allie Beth Stuckey that one of the co-plaintiffs in the case was coerced into a chemical abortion by her boyfriend, who threatened her if she didn’t take the drugs.
“Thankfully, the Fifth Circuit recognized that this is a real, active danger to state pro-life laws, but also to individual women who are being harmed and, of course, pre-born children who are being harmed by these drugs,” Francis explains.
“And so, the Fifth Circuit said,
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!